Breast Cancer CME Courses

Breast Cancer CME Courses

Credits: 25 (AMA PRA Category 1)
Format: DVD
Price: $695
Release Date: 3/15/2017
Expiration Date: 3/14/2020
Summary:

Course Highlights:

  • Contains all new content, constructed to meet the ACR CME requirement for facility accreditation in Breast MR.
  • Case reviews for review of malignant and benign disease, featuring nodules, tumors and patterns of enhancement encountered in every day practice. Includes foundational breast MR lectures on indications, imaging techniques, epidemiology of breast cancer and risk stratification
  • Covers topics such as benign enhancement patterns and foci of enhancement, fibroadenomas, papillomas, lymph nodes, DCIS, invasive malignancies both ductal and lobular, male breast cancer, patterns of nodal spread, synchronous and contralateral tumors, response to neoadjuvant chemotherapy, skin and nipple involvement, phyllodes tumors, radial scars and much more
  • Available in both DVD and online formats.
Credits: 17 (AMA PRA Category 1)
Format: Online Streaming Video, DVD
Price: $695
Release Date: Nov 15, 2018
Expiration Date: Nov 14, 2021
Summary:

Duke Radiology’s 8th Mammograms to MRI is designed to provide a comprehensive review of established breast imaging modalities along with an update to the many advances in techniques.  Practical advice will cultivate a complete discussion of analog and digital mammography, breast ultrasound, MRI and interventions.  This strong foundation promotes an exploration of newer technologies, such as tomosynthesis.  As such, the 17 AMA PRA Category I Credits™ available in this activity meet MQSA CME requirements, and all credits count as SA-CME for Maintenance of Certification.

Topics:  2D and 3D mammography, screening, Breast Cancer, biopsy, Breast MRI, Ultrasound, BIRADS, Lymph Nodes, High Risk Lesions, Surgery, Tomosynthesis and much more!

Credits: 0.75 (CE)
Format: Online Streaming Video, Interactive Online, Multiple Formats
Price: Free
Release Date: Nov 17, 2017
Expiration Date: Nov 17, 2019
Summary:

By the end of the session the participant will be able to:

  • Apply screening criteria to a patient receiving AI therapy or androgen deprivation therapy
  • Describe the criteria for initiation of pharmacotherapy in a patient receiving AI therapy or androgen deprivation therapy and apply them to a patient case
  • Identify present pharmacotherapeutic treatments for management of a patient receiving AI therapy or androgen deprivation therapy, and describe their mechanisms of action and place in therapy
  • Describe the challenges associated with treating patients receiving AI or androgen deprivation therapies, focus specifically on the risks (e.g., adverse drug reactions, drug interactions, et cetera) of the agents and apply the information in optimizing patient care in a patient case




Share This